ExploreWatchlistsPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Stockholders' equity

Mochida Pharmaceutical Co.,Ltd. (4534)

Market cap
¥123.9B
P/E ratio
14.4x
A Japanese pharmaceutical company that develops and sells prescription drugs and healthcare products through a network of manufacturing and sales subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2025130,694+2.13%
Mar 31, 2024127,967+0.94%
Mar 31, 2023126,775-1.45%
Mar 31, 2022128,646+1.32%
Mar 31, 2021126,974+5.23%
Mar 31, 2020120,665-3.55%
Mar 31, 2019125,110+4.53%
Mar 31, 2018119,687+6.99%
Mar 31, 2017111,869+6.61%
Mar 31, 2016104,929+6.34%
Mar 31, 201598,670+5.32%
Mar 31, 201493,688

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat